The Many Faces of Long Noncoding RNAs in Cancer.
Antioxid Redox Signal
; 29(9): 922-935, 2018 09 20.
Article
in En
| MEDLINE
| ID: mdl-28793797
SIGNIFICANCE: The emerging connections between an increasing number of long noncoding RNAs (lncRNAs) and oncogenic hallmarks provide a new twist to tumor complexity. Recent Advances: In the present review, we highlight specific lncRNAs that have been studied in relation to tumorigenesis, either as participants in the neoplastic process or as markers of pathway activity or drug response. These transcripts are typically deregulated by oncogenic or tumor-suppressing signals or respond to microenvironmental conditions such as hypoxia. CRITICAL ISSUES: Among these transcripts are lncRNAs sufficiently divergent between mouse and human genomes that may contribute to biological differences between species. FUTURE DIRECTIONS: From a translational standpoint, knowledge about primate-specific lncRNAs may help explain the reason behind the failure to reproduce the results from mouse cancer models in human cell-based systems. Antioxid. Redox Signal. 29, 922-935.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
RNA, Long Noncoding
/
Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Antioxid Redox Signal
Journal subject:
METABOLISMO
Year:
2018
Document type:
Article
Country of publication: